about
Atlas of the clinical genetics of human dilated cardiomyopathyDynamic conduction and repolarisation changes in early arrhythmogenic right ventricular cardiomyopathy versus benign outflow tract ectopy demonstrated by high density mapping & paced surface ECG analysis.Recurrent missense mutations in TMEM43 (ARVD5) due to founder effects cause arrhythmogenic cardiomyopathies in the UK and Canada.Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathyThe structural effects of mutations can aid in differential phenotype prediction of beta-myosin heavy chain (Myosin-7) missense variants.Electrophysiological abnormalities precede overt structural changes in arrhythmogenic right ventricular cardiomyopathy due to mutations in desmoplakin-A combined murine and human study.The current role of next-generation DNA sequencing in routine care of patients with hereditary cardiovascular conditions: a viewpoint paper of the European Society of Cardiology working group on myocardial and pericardial diseases and members of theEpicardial myocardial strain abnormalities may identify the earliest stages of arrhythmogenic cardiomyopathy.Abnormal cardiac formation in hypertrophic cardiomyopathy: fractal analysis of trabeculae and preclinical gene expression.Use of high-throughput targeted exome-sequencing to screen for copy number variation in hypertrophic cardiomyopathy.A novel Myosin essential light chain mutation causes hypertrophic cardiomyopathy with late onset and low expressivityLamin and the heart.Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation.Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy: disease expression in relation to age, gender, and long term outcome.Genetic basis of arrhythmogenic cardiomyopathy.Diagnostic yield of molecular autopsy in patients with sudden arrhythmic death syndrome using targeted exome sequencing.Clinical Significance of Epsilon Waves in Arrhythmogenic CardiomyopathyFamilial Evaluation in Arrhythmogenic Right Ventricular CardiomyopathyMutational Heterogeneity, Modifier Genes, and Environmental Influences Contribute to Phenotypic Diversity of Arrhythmogenic CardiomyopathyPrevalence of Desmosomal Protein Gene Mutations in Patients With Dilated CardiomyopathyPrevalence of F-fluorodeoxyglucose positron emission tomography abnormalities in patients with arrhythmogenic right ventricular cardiomyopathyLamin mutation location predicts cardiac phenotype severity: combined analysis of the published literatureProteomic Analysis of the Myocardium in Hypertrophic Obstructive CardiomyopathyUnique epidermolytic bullous dermatosis with associated lethal cardiomyopathy related to novel desmoplakin mutationsHypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM): A Randomized, Placebo-Controlled, Double-Blind Pilot StudyFrequency of genetic variants associated with arrhythmogenic right ventricular cardiomyopathy in the genome aggregation databaseA microRNA Expression Profile as Non-Invasive Biomarker in a Large Arrhythmogenic Cardiomyopathy CohortNo major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathyHeart failure in patients with arrhythmogenic right ventricular cardiomyopathy: Genetic characteristics
P50
Q28246768-B99CC572-86A7-4CF1-8A64-426B69E2EC4DQ33889845-5F9639F0-34E5-453A-B0EC-0480CF5714DCQ34312480-E61F63F1-166B-44BD-A73C-CEA71A8FA92BQ34445272-379685F7-C43A-47AF-B6DE-086752080463Q36056126-D6F8EEEA-768E-4A70-BDF9-916DCD280BD8Q36131473-E92376E2-6AF3-46CA-A0FB-8C4B1089E75EQ38407538-2CA24F9D-78EE-481F-946B-41D8EF9E698CQ38420171-D1153431-2708-4F3B-BEB6-478B04C4A438Q38439614-B880AF13-82A1-483C-98CE-5A06DB63DE43Q40444308-1B0C6D87-A400-433E-A26D-4CEAE551480FQ42173357-EA44B8E6-7525-4F9D-B0C3-88F2DE6DD956Q47364325-FAA331B5-171F-4C2C-8618-46C6BC408FCCQ50990533-76352DEB-5EA6-451B-8A87-FD9E43B27776Q51176357-C0C952F0-19CE-4D66-AB76-4C550893790CQ52654099-1ACDB697-6FB4-4D68-9371-6EC4630A1B0BQ54966607-54C17C8C-C999-447F-A159-0A305CC3B416Q57901708-B27EB4D4-4AE9-45B5-AD8A-03AC1681F858Q57901803-15FF2007-3EE2-40F7-9FC7-D29642122349Q57901839-9BF5F2C6-C59C-4C03-B7DE-E42231FD0A7BQ57901844-5605A103-22CF-48E8-AACD-4B8A32118A27Q58543351-CFF6CA28-EFB8-4FEC-885A-E4612EFD85B4Q58561653-4415C747-EE93-4297-A344-6080A38FCEFAQ61847874-ACC76D96-04F8-4795-A500-5FECEF096E33Q83261959-0D0A0303-FFE5-47E7-A00D-CAFF5265CC9CQ88058627-BE423C74-3F22-4792-97F3-E929994B0F1FQ88867619-AEEC8394-37CE-485E-8458-0706686C4AE1Q89896244-C3411181-933F-4170-BEE2-B4432177D168Q91223759-14F88C3C-2712-4436-BEED-B8C62E60EC11Q91593015-BED57AC0-D2C3-4643-BA21-5C338FE4FDA2
P50
description
researcher ORCID ID = 0000-0002-2363-8758
@en
wetenschapper
@nl
name
Petros Syrris
@ast
Petros Syrris
@en
Petros Syrris
@es
Petros Syrris
@nl
type
label
Petros Syrris
@ast
Petros Syrris
@en
Petros Syrris
@es
Petros Syrris
@nl
prefLabel
Petros Syrris
@ast
Petros Syrris
@en
Petros Syrris
@es
Petros Syrris
@nl
P31
P496
0000-0002-2363-8758